Concord Wealth Partners - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 26 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$98,066
-25.9%
15,275
-14.1%
0.02%
-44.7%
Q1 2023$132,424
+70.5%
17,7750.0%0.04%
+65.2%
Q4 2022$77,677
-22.3%
17,7750.0%0.02%
-28.1%
Q3 2022$100,000
-2.9%
17,7750.0%0.03%
+14.3%
Q2 2022$103,000
-39.4%
17,775
+6.0%
0.03%
-36.4%
Q1 2022$170,000
+60.4%
16,775
+31.3%
0.04%
+69.2%
Q4 2021$106,00012,7750.03%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 750,000$7,605,0008.16%
K.J. Harrison & Partners Inc 1,351,782$13,749,0002.21%
Redmond Asset Management, LLC 137,942$1,399,0000.42%
SABBY MANAGEMENT, LLC 29,962$304,0000.04%
Concord Wealth Partners 16,775$170,0000.04%
Leonard Green & Partners, L.P. 500,000$5,070,0000.04%
Summit Trail Advisors, LLC 35,000$355,0000.03%
WASATCH ADVISORS LP 244,691$2,481,0000.01%
Apollon Wealth Management, LLC 13,900$141,0000.01%
NATIONAL BANK OF CANADA /FI/ 156,900$1,591,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders